Abstract
Remote monitoring to manage heart failure (HF) at home can reduce readmission rates. Notably the implantable CardioMEMS device that measures pulmonary artery pressure (PAP) has proven effective but is both invasive and costly. Our goal is to develop smart home sensors that can monitor HF patients non-invasively and without requiring active patient engagement. The objective of this study is the development and evaluation of ballistocardiography (BCG) as a candidate technology for non-invasive, autonomous monitoring of PAP for HF patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
